Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia (Q44675402)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37829812)
(P304) 258-264
(P433) 4
(P478) 83
(P577) Saturday, November 29, 2003
(P921) (Q729735)
(Q177094)
(P1433) (Q15766509)
(P1476) "Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia" (language: en)
(P2093) U Berger
G Engelich
A Reiter
R Hehlmann
German CML Study Group
other details
description scientific article

External Links